JP2019534332A5 - - Google Patents

Download PDF

Info

Publication number
JP2019534332A5
JP2019534332A5 JP2019545906A JP2019545906A JP2019534332A5 JP 2019534332 A5 JP2019534332 A5 JP 2019534332A5 JP 2019545906 A JP2019545906 A JP 2019545906A JP 2019545906 A JP2019545906 A JP 2019545906A JP 2019534332 A5 JP2019534332 A5 JP 2019534332A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
polymorph
solvate
acceptable salt
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019545906A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019534332A (ja
JP7098643B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/060840 external-priority patent/WO2018089621A1/en
Publication of JP2019534332A publication Critical patent/JP2019534332A/ja
Publication of JP2019534332A5 publication Critical patent/JP2019534332A5/ja
Application granted granted Critical
Publication of JP7098643B2 publication Critical patent/JP7098643B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019545906A 2016-11-09 2017-11-09 Hiv/aidsに対する強力な三環式p2リガンド含有hivプロテアーゼ阻害剤 Active JP7098643B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662419850P 2016-11-09 2016-11-09
US62/419,850 2016-11-09
PCT/US2017/060840 WO2018089621A1 (en) 2016-11-09 2017-11-09 Tricyclic p2-ligand containing potent hiv-protease inhibitors against hiv/aids

Publications (3)

Publication Number Publication Date
JP2019534332A JP2019534332A (ja) 2019-11-28
JP2019534332A5 true JP2019534332A5 (cg-RX-API-DMAC7.html) 2021-07-26
JP7098643B2 JP7098643B2 (ja) 2022-07-11

Family

ID=62110761

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019545906A Active JP7098643B2 (ja) 2016-11-09 2017-11-09 Hiv/aidsに対する強力な三環式p2リガンド含有hivプロテアーゼ阻害剤

Country Status (5)

Country Link
US (2) US11028096B2 (cg-RX-API-DMAC7.html)
EP (1) EP3538090B1 (cg-RX-API-DMAC7.html)
JP (1) JP7098643B2 (cg-RX-API-DMAC7.html)
DK (1) DK3538090T3 (cg-RX-API-DMAC7.html)
WO (1) WO2018089621A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7098643B2 (ja) 2016-11-09 2022-07-11 パーデュー・リサーチ・ファウンデーション Hiv/aidsに対する強力な三環式p2リガンド含有hivプロテアーゼ阻害剤
CN109251208B (zh) * 2018-09-29 2020-03-20 山东农业大学 呋喃并吡喃衍生物在小麦田间防冻管理中的用途
CA3171361A1 (en) * 2020-03-18 2021-09-23 Arun K. Ghosh Tricyclic p2-ligand containing potent hiv-protease inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5946937B2 (ja) * 1975-12-30 1984-11-15 東レ株式会社 プロスタグランジンゴウセイチユウカンタイノセイゾウホウ
JPS5524139A (en) 1978-08-11 1980-02-21 Toray Ind Inc Optically active intermediate and its preparation
JPH05283436A (ja) 1992-03-31 1993-10-29 Hitachi Ltd パターン形成方法およびこの方法を用いたオフセットゲート電界効果トランジスタの製造方法
JPH0848678A (ja) 1994-06-02 1996-02-20 Banyu Pharmaceut Co Ltd 三環性ラクトン化合物の製造法
CN100338067C (zh) * 2004-09-24 2007-09-19 中国科学院昆明植物研究所 抗艾滋病化合物,其制备方法和以该类化合物为活性成分的药物组合物及其应用
WO2012031237A1 (en) 2010-09-02 2012-03-08 Purdue Research Foundation Fused tricyclic ether carbamates and their use
WO2012092188A1 (en) 2010-12-27 2012-07-05 Ghosh Arun K Hydrogen bond forming p1 ligands and methods for treating hiv
WO2015175994A1 (en) * 2014-05-16 2015-11-19 Ghosh Arun K Hiv-1 protease inhibitors and uses thereof
JP7098643B2 (ja) 2016-11-09 2022-07-11 パーデュー・リサーチ・ファウンデーション Hiv/aidsに対する強力な三環式p2リガンド含有hivプロテアーゼ阻害剤

Similar Documents

Publication Publication Date Title
JP2016514159A5 (cg-RX-API-DMAC7.html)
JP2015024998A5 (cg-RX-API-DMAC7.html)
JP2009263394A5 (cg-RX-API-DMAC7.html)
JP2012092103A5 (cg-RX-API-DMAC7.html)
ZA202006378B (en) N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
CY1118621T1 (el) Πολυμορφικες μορφες του 2-(5-βρωμο-4-(4-κυκλο προπυλναφθαλιν-1-υλ)-4η-1,2,4-τριαζολ-3-υλθειο) οξικου οξεος και χρησεις αυτων
JP2018537413A5 (ja) 化合物、医薬的に許容される塩又はその立体異性体及び医薬組成物
JP2011219498A5 (cg-RX-API-DMAC7.html)
JP2016510323A5 (cg-RX-API-DMAC7.html)
JP2005053931A5 (cg-RX-API-DMAC7.html)
JP2015535839A5 (cg-RX-API-DMAC7.html)
JP2015051983A5 (cg-RX-API-DMAC7.html)
JP2017504635A5 (cg-RX-API-DMAC7.html)
JP2010527913A5 (cg-RX-API-DMAC7.html)
JP2019510034A5 (cg-RX-API-DMAC7.html)
JP2018501215A5 (cg-RX-API-DMAC7.html)
JP2016505614A5 (cg-RX-API-DMAC7.html)
JP2020529994A5 (cg-RX-API-DMAC7.html)
JP2014526554A5 (cg-RX-API-DMAC7.html)
JP2019510027A5 (cg-RX-API-DMAC7.html)
MX2018009944A (es) Procedimiento para la preparacion del acido 4-fenil-5-alcoxicarbon il-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]3-oxo-5,6,8,8a- tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxilico.
JP2015535847A5 (cg-RX-API-DMAC7.html)
JP2015508092A5 (cg-RX-API-DMAC7.html)
JP2017536416A5 (cg-RX-API-DMAC7.html)
JP2015199738A5 (cg-RX-API-DMAC7.html)